About EGOV NIC Inc. (NASDAQ : EGOV) is a digital software and services provider for federal, state and local governments. Recognized in 2013 as one of America’s best small companies by Forbes, EGOV has been in the news in February…
Square (NYSE: SQ) A Problem Solver Square (NYSE: SQ) is a Fintech leader which provides hardware and software solutions to small businesses and individuals. Square’s Cash App solves a variety of problems. It’s a platform to send and receive money,…
Foresight Autonomous Holdings shares Gap Up After Announcement Foresight Autonomous Holdings (FRSX) announced on March 12th 2021 that its wholly owned subsidiary, Eye-Net Mobile Ltd,. has completed a pilot project in the first phase of testing. The project was with…
Qualtrics Customer Service Team Qualtrics has won two Stevie® Silver customer service awards. Qualric’s customer service team has been recognized for “Best Technology Use” for an innovative support portal with a volume increase of 40%. Work satisfaction has improved 10…
Lordstown Motors (RIDE) Challenges Hindenburg Research Report Accusing the company of Fraud Electric truck startup Lordstown Motors Corporation RIDE 16.54%has aggressively challenged a report from Hindenburg Research that reports the firm of fraudulently marketing itself. What Happened: Hindenburg’s reports”The Lordstown…
Technology Stocks: Recent Gainers Technology Stocks have been experiencing lots of market volatility. Below is a list of stocks that have seen positive upside movement in the past week. NLS Pharmaceutics AGNLSP 85.16%shares jumped 87.3% to $5.30 in reaction to…
Technology Losers for the Day Poshmark, Inc.POSH 20.14%decreased by 19.9% to $47.65 per share after the firm announced Q4 earnings results. Evoke Pharma, Inc. EVOK 22.58%decreased by 19.5% to $2.4950 per share after the firm announced Q4 earnings results. Medalist…
Acadia Pharmaceuticals: Defect Found in Supplement The health of a pharmaceutical company depends on the feedback of new drug candidates. A positive regulatory reaction almost always leads to a sharp rise in stock prices. Conversely, a refusal will force investors…
Blue Bird Bio Experimental Gene Therapy Blue Bird Bio (BLUE) said that experimental gene therapy for blood disorders are probably not the cause of patient cancer. The announcement increases the popularity of BLUE leading to a rise in the stock…
ZNGA Q4 Loss Despite Growth for the Year About a month has passed since the latest release of ZNGA. During this period, the stock price fell around 14.8% and lags behind the S&P 500. Will the recent negative trend for…
